Westlaw Journal
Pandemic and Internal Investigations: Risks and Considerations in Light of COVID-19
May 12, 2020
In light of the unprecedented scope and severity of the novel coronavirus (COVID-19), governments and private entities across the globe are undertaking a variety of dramatic steps intended to halt the spread of the disease.
These drastic changes have left businesses scrambling to manage compliance risk and to confront the realities of a significantly altered economic environment.
Offices
Capabilities
Suggested News & Insights
Sidley Clinches Victory in HEC AD/CVD InvestigationsJanuary 30, 2026Sidley Represents Glenfarne as Principal Project Counsel on Alaska LNGJanuary 29, 2026Sidley Advises Marathon Asset Management on its up to US$1.6 Billion Sale to CVCJanuary 26, 2026Sidley Advises on Market-Defining Cross-Border India Matters in 2025January 12, 2026New U.S. Executive Order Targets Stock Buybacks, Dividends, and Executive Compensation for Underperforming Defense ContractorsJanuary 9, 2026Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
